245
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Placental growth factor as a predictive marker of preeclampsia – PREBIO study – PREeclampsia BIOchemical study

, , , , , , & show all
Pages 3029-3035 | Received 20 Dec 2019, Accepted 03 Jul 2020, Published online: 20 Jul 2020

References

  • Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00070-7/fulltext#.WiuWBr0ztkE.mendeley.
  • Roberts JM, August PA, Bakris G, et al. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
  • Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–975.
  • Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci. 2012;122(2):43–52.
  • Sahai K, Saraswathy S, Yadav TP, et al. Pre-eclampsia: molecular events to biomarkers. Med J Armed Forces India. 2017;73(2):167–174. [cited 2017 Dec 9]Available from: http://www.ncbi.nlm.nih.gov/pubmed/28924318.
  • Ukah UV, Hutcheon JA, Payne B, et al. Placental growth factor as a prognostic tool in women with hypertensive disorders of pregnancy: a systematic review. Hypertension. 2017;70(6):1228–1237.
  • Adamson SL. SFLT1 in preeclampsia: trophoblast defense against a decidual VEGFA barrage? J Clin Invest. 2014;124(11):4690–4692.
  • Saffer C, Olson G, Boggess KA, et al. Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertens. 2013;3(2):124–132.
  • Rădulescu C, Bacârea A, Huțanu A, et al. Placental growth factor, soluble fms-like tyrosine kinase 1, soluble endoglin, IL-6, and IL-16 as biomarkers in preeclampsia. Mediators Inflamm. 2016;2016:3027363.
  • Chappell LC, Duckworth S, Griffin M, et al. OS100. Plasma placental growth factor (PLGF) measurement in women presenting with suspected pre-eclampsia: the pelican study. Pregnancy Hypertens. 2012;2(3):233–234.
  • Redman C. Diagnostic and predictive accuracy of placental growth factor in suspected pre-eclampsia. Pregnancy Hypertens. 2014;4(3):241.
  • Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22.
  • NICE. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio). Diagnostic Guid 23. 2016.
  • [cited 2020 July 7]. Available from: http://www.awmf.org/uploads/tx_szleitlinien/037-012l_S1_Lipoedem_2016-01.pdf.
  • Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51(3):353–361.
  • Gordijn SJ, Beune IM, Thilaganathan B, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333–339.
  • Von See J, Limperger V, Pecks U, et al. Influences on Placental Growth Factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) concentration levels at the time of first trimester screening. Z Geburtshilfe Neonatol. 2016;220(04):166–172.
  • Meher A, Sundrani D, Joshi S. Maternal nutrition influences angiogenesis in the placenta through peroxisome proliferator activated receptors: a novel hypothesis. Mol Reprod Dev. 2015;82(10):726–734.
  • Eleftheriades M, Papastefanou I, Lambrinoudaki I, et al. Elevated placental growth factor concentrations at 11–14 weeks of gestation to predict gestational diabetes mellitus. Metabolism. 2014;63(11):1419–1425.
  • Huynh J, Dawson D, Roberts D, et al. A systematic review of placental pathology in maternal diabetes mellitus. Placenta. 2015;36(2):101–114.
  • Mosimann B, Amylidi S, Risch L, et al. First-trimester placental growth factor in screening for gestational diabetes. Fetal Diagn Ther. 2016;39(4):287–291.
  • Benton SJ, McCowan LM, Heazell AEP, et al. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta. 2016;42:1–8.
  • Triunfo S, Lobmaier S, Parra-Saavedra M, et al. Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion. Placenta. 2014;35(6):398–403.
  • Redman CWG, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213(4):S9.e1–S9.e4.
  • Vatish M, Strunz-McKendry T, Hund M, et al. sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK. Ultrasound Obstet Gynecol. 2016;48(6):765–771.
  • Duckworth S, Chappell LC, Seed PT, et al. Placental growth factor (PLGF) in women with suspected pre-eclampsia prior to 35 weeks’ gestation: a budget impact analysis. PLoS One. 2016;11(10):e0164276.
  • Cox LS, Redman C. The role of cellular senescence in ageing of the placenta. Placenta. 2017;52:139–145.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.